Platelet Serotonin and Platelet Aggregation in the Differential Diagnosis of Thrombocytosis

Thromb Haemost 1982; 48(03): 343
DOI: 10.1055/s-0038-1657298

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

F Fabris

Institute of Medical Semeiotics and Second Chair of Medicine, University of Padua Medical School, Padua, Italy
M Randi

Institute of Medical Semeiotics and Second Chair of Medicine, University of Padua Medical School, Padua, Italy
A Casonato

Institute of Medical Semeiotics and Second Chair of Medicine, University of Padua Medical School, Padua, Italy
N Scattolo

Institute of Medical Semeiotics and Second Chair of Medicine, University of Padua Medical School, Padua, Italy
A Girolami

Institute of Medical Semeiotics and Second Chair of Medicine, University of Padua Medical School, Padua, Italy

References
1 Pareti FI, Gugliotta L, Mannucci L, Guarini A, Mannucci PM. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders. Thromb Haemostas 1982; 47: 84-89
2 Caranobe C, Sie P, Nouvel C, Laurent G, Pris J, Boneu B. Platelets and myeloproliferative disorders. Scand J Haematol 1980; 25: 289-295
3 Weinfield A, Branehög I, Kutti J. Platelets in myeloproliferative syndrome. Clin Haematol 1975; 4: 373-392
4 Fabris F, Randi M, Sbrojavacca R, Casonato A, Girolami A. The possible value of platelet aggregation studies in patients with increased platelet number. Blut 1981; 43: 279-285
5 Zucker S, Mielke CH. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications. J Lab Clin Med 1972; 80: 385-393
6 Udenfriend S, Weissbach H, Clark CT. The estimation of 5-Hydroxy-tryptamine (serotonin) in biological tissues. J Biol Chem 1955; 215: 337-344
7 Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of Medical Diagnosis. John Wiley; New York: 1975: 175-187